Brentuximab Vedotin and AVD Chemotherapy Followed by ISRT: A Safe Primary Treatment Regimen for Early-Stage, Unfavorable Hodgkin Lymphoma.

Subjects

Subjects :

*HODGKIN'S disease treatment
*CANCER chemotherapy
*RADIOTHERAPY safety
*DOXORUBICIN
*CANCER radiotherapy

Details

Language :

English

ISSN :

03603016

Volume :

96

Database :

Academic Search Index

Journal :

International Journal of Radiation Oncology, Biology, Physics

Publication Type :

Academic Journal

Accession number :

117553627

Full Text :

https://doi.org/10.1016/j.ijrobp.2016.06.064